Lobo Félix, Oliva Juan, Vida José
Departamento de Economía, Facultad de Ciencias Sociales y Jurídicas, Universidad Carlos III de Madrid, Getafe (Madrid), España; Fundación de Cajas de Ahorros (FUNCAS), Madrid, España.
Departamento de Análisis Económico y Finanzas, Facultad de Ciencias Jurídicas y Sociales, Universidad de Castilla-La Mancha, Toledo, España; CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), España.
Gac Sanit. 2024;38:102417. doi: 10.1016/j.gaceta.2024.102417. Epub 2024 Aug 1.
We describe in detail a twofold proposal for the creation, organization and sequential development of two bodies responsible for evaluating the efficiency of health technologies and policies in Spain and its possible design. It would constitute a key element in the process of re-organising the National Health System. The first, which could be adopted immediately, would be called the Office for the Evaluation of the Efficiency of Medicines, would be attached to the Spanish Agency for Medicines and Medical Devices as a functionally independent body and limited to evaluating the efficiency of medicines. The second, the National Health Evaluation Commission, in the form of an independent administrative body, would evaluate health technologies and possibly public health policies. Functional independence, adequate resources and anchoring in the values of good governance are the defining characteristics of this dual proposal.
我们详细阐述了一项双重提议,内容涉及创建、组织并按序发展两个负责评估西班牙卫生技术与政策效率及其可能设计的机构。这将成为国家卫生系统重组进程中的关键要素。第一个机构可立即采用,称为药品效率评估办公室,作为一个功能独立的机构附属于西班牙药品和医疗器械局,且仅限于评估药品效率。第二个机构是国家卫生评估委员会,作为一个独立的行政机构,将评估卫生技术以及可能的公共卫生政策。功能独立、充足资源以及秉持善治价值观是这一双重提议的显著特征。